Chenghao Pan

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation

Chengyu Shi, Ying Wang, Minjie Wu et al. · Nature Communications · 2022 · 78 citations · Full text

Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitors

Chenghao Pan, Wenwen Nie, Jiao Wang et al. · European Journal of Medicinal Chemistry · 2021 · 21 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +12

Identification of Potential WSB1 Inhibitors by AlphaFold Modeling, Virtual Screening, and Molecular Dynamics Simulation Studies

Ye Weng, Chenghao Pan, Zheyuan Shen et al. · Evidence-based Complementary and Alternative Medicine · 2022 · 21 citations · Full text

Design, synthesis and biological evaluation of new dihydropyridine derivatives as PD-L1 degraders for enhancing antitumor immunity

Chenghao Pan, Mengxin Luo, Yang Lu et al. · Bioorganic Chemistry · 2022 · 14 citations

Medicinal Chemistry, Pd-l1 Degraders, Medicine +8

Design, synthesis, and biological evaluation of quinazoline derivatives with covalent reversible warheads as potential FGFR4 inhibitors

Wenwen Nie, Yang Lu, Chenghao Pan et al. · Bioorganic Chemistry · 2022 · 13 citations

Combinatorial Chemistry, Medicinal Chemistry, Potential Fgfr4 Inhibitors +9